Determination of glibenclamide in Xiaotangling Capsule by HPLC;

Effects of Metformin combining with Glibenclamide in type 2 diabetes mellitus;

Qualitative identification of glibenclamide added in poria and rhizoma dioscoreae tablets;

Separation and Determination of the Isomer of Glimepiride Using HPLC;

HPLC determination of a new antidiabetic drug: glimepiride.;

The Effects of Short-term Intensive Therapy with Glargine Versus Glimepiride on β-cell Function in Newly Diagnosed Type 2 Diabetic Patients;

Determination of Glibenclamide in Human Plasma by HPLC-MS/MS;

Examination of glibenclamide added in Shiwei Yuquan capsule;

Determination of Glibenclamide in Human Plasma by LC-MS and Study of Its Pharmacokinetics in Healthy Chinese Volunteers;

Detection of phenformin and glyburide illegally mixed into traditional Chinese medicine antidiabetic preparations by the liquid chromatography-mass spectrometry method;

Pharmacokinetics of fixed-combination glyburide/metformin hydrochloride tablets in healthy subjects;

UPLC/MS/MS determination of glyburide and glipizide added in traditional Chinese medicinal preparation;

Pharmaceutical study of compound metformin hydrochloride and micronized glyburide;

Available evidences support that glyburide can be used in treatment of GDM and metformin could be used in treatment of pregestational diabetes mellitus and diabetes mellitus in early pregnancy.